These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12720527)

  • 21. Defining dual diagnosis of mental illness and substance misuse: some methodological issues.
    Todd J; Green G; Harrison M; Ikuesan BA; Self C; Baldacchino A; Sherwood S
    J Psychiatr Ment Health Nurs; 2004 Feb; 11(1):48-54. PubMed ID: 14723639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
    Alegría M; Falgas-Bague I; Collazos F; Carmona Camacho R; Lapatin Markle S; Wang Y; Baca-García E; Lê Cook B; Chavez LM; Fortuna L; Herrera L; Qureshi A; Ramos Z; González C; Aroca P; Albarracín García L; Cellerino L; Villar A; Ali N; Mueser KT; Shrout PE
    JAMA Netw Open; 2019 Jan; 2(1):e186927. PubMed ID: 30646205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use and psychosis.
    Pawsey B; Castle D
    Aust Fam Physician; 2006 Mar; 35(3):110-2. PubMed ID: 16525520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine.
    McPhillips MA; Kelly FJ; Barnes TR; Duke PJ; Gene-Cos N; Clark K
    Schizophr Res; 1997 May; 25(2):141-8. PubMed ID: 9187013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving care for depression in patients with comorbid substance misuse.
    Watkins KE; Paddock SM; Zhang L; Wells KB
    Am J Psychiatry; 2006 Jan; 163(1):125-32. PubMed ID: 16390899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of substance use disorders in schizophrenia.
    Bennett ME; Bradshaw KR; Catalano LT
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):377-390. PubMed ID: 27715317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): cluster randomised trial.
    Johnson S; Thornicroft G; Afuwape S; Leese M; White IR; Hughes E; Wanigaratne S; Miles H; Craig T
    Br J Psychiatry; 2007 Nov; 191():451-2. PubMed ID: 17978327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How successful is the dual diagnosis good practice guide?
    Laker C
    Br J Nurs; 2006 Jul 27-Aug 9; 15(14):787-90. PubMed ID: 16936621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbid addiction and major mental illness in Europe: a narrative review.
    Carrà G; Bartoli F; Brambilla G; Crocamo C; Clerici M
    Subst Abus; 2015; 36(1):75-81. PubMed ID: 25222286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia.
    Kingston REF; Marel C; Mills KL
    Drug Alcohol Rev; 2017 Jul; 36(4):527-539. PubMed ID: 27786426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical guidelines for the management of schizophrenia (ΙΙ): Community service-level interventions and the role of Primary Care].
    Margariti M; Hadjulis M; Lazaridou M; Angelidis GF; Fotopoulos V; Markaki L; Koulouri F
    Psychiatriki; 2018; 29(2):118-129. PubMed ID: 30109852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using NIATx strategies to implement integrated services in routine care: a study protocol.
    Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP
    BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinician screening and treatment of alcohol, drug, and mental problems in primary care: results from healthcare for communities.
    Edlund MJ; Unützer J; Wells KB
    Med Care; 2004 Dec; 42(12):1158-66. PubMed ID: 15550795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough.
    Weaver T; Rutter D; Madden P; Ward J; Stimson G; Renton A
    Soc Psychiatry Psychiatr Epidemiol; 2001 Aug; 36(8):399-406. PubMed ID: 11766970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.
    Haddock G; Barrowclough C; Tarrier N; Moring J; O'Brien R; Schofield N; Quinn J; Palmer S; Davies L; Lowens I; McGovern J; Lewis S
    Br J Psychiatry; 2003 Nov; 183():418-26. PubMed ID: 14594917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.